Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.

[1]  A. Ruffatti,et al.  Laboratory diagnosis of antiphospholipid syndrome. , 2011, Reumatismo.

[2]  R. Caporali,et al.  [Plasma procalcitonin in rheumatic diseases]. , 2011, Reumatismo.

[3]  陶仲为.  Sarcoidosis , 2009 .

[4]  B. Feldman,et al.  Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood , 2008, The Lancet.

[5]  C. Kozinetz,et al.  Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis , 2008, Pediatric blood & cancer.

[6]  M. Sormani,et al.  A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. , 2008, Arthritis and rheumatism.

[7]  T. Moore,et al.  Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology , 2008, Current rheumatology reports.

[8]  E. Silverman,et al.  Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. , 2008, The Journal of pediatrics.

[9]  K. Mertens,et al.  Mechanisms of Disease: antiphospholipid antibodies—from clinical association to pathologic mechanism , 2008, Nature Clinical Practice Rheumatology.

[10]  K. Migita,et al.  Serum amyloid A‐induced IL‐6 production by rheumatoid synoviocytes , 2008, FEBS letters.

[11]  Y. Shoenfeld,et al.  Autoantibody explosion in antiphospholipid syndrome. , 2008, Journal of autoimmunity.

[12]  J. Piette,et al.  Antiphospholipid antibodies, antiphospholipid syndrome and infections. , 2008, Autoimmunity reviews.

[13]  S. Ikeda.  [Diagnosis and treatment in systemic amyloidosis]. , 2008, Rinsho byori. The Japanese journal of clinical pathology.

[14]  G. Tzelepis,et al.  The presence of anti‐centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis , 2008, Scandinavian journal of rheumatology.

[15]  D. Lacks,et al.  Ferritin levels in children with severe sepsis and septic shock , 2007, Acta paediatrica.

[16]  L. Wedderburn,et al.  Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. , 2007, Rheumatology.

[17]  B. Chiang,et al.  Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients. , 2007, Rheumatology.

[18]  B. Chiang,et al.  Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in juvenile rheumatoid arthritis. , 2007, Clinical and experimental rheumatology.

[19]  Y. Shoenfeld,et al.  Ferritin in autoimmune diseases. , 2007, Autoimmunity reviews.

[20]  Caroline A Sabin,et al.  Natural history and outcome in systemic AA amyloidosis. , 2007, The New England journal of medicine.

[21]  M. Chalumeau,et al.  Procalcitonine semi-quantitative aux urgences pédiatriques , 2007 .

[22]  P. Geusens,et al.  Analyses of immunosenescent markers in patients with autoimmune disease. , 2007, Clinical immunology.

[23]  D. Booth,et al.  Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. , 2007, Arthritis and rheumatism.

[24]  D. Jabs,et al.  Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. , 2007, American journal of ophthalmology.

[25]  M. Nobuyoshi,et al.  The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis Published, JLR Papers in Press, January 29, 2007. , 2007, Journal of Lipid Research.

[26]  D. Gendrel,et al.  LACK OF VALUE OF PROCALCITONIN FOR PREDICTION OF CORONARY ANEURYSMS IN KAWASAKI DISEASE , 2007, The Pediatric infectious disease journal.

[27]  L. Truedsson,et al.  Complement deficiencies and systemic lupus erythematosus , 2007, Autoimmunity.

[28]  S. Revel-Vilk,et al.  Antiphospholipid syndrome and recurrent thrombosis in children. , 2006, Arthritis and rheumatism.

[29]  J. Brunner,et al.  Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis , 2006, Modern rheumatology.

[30]  P. Woo,et al.  Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. , 2006, Arthritis and rheumatism.

[31]  I. Targoff,et al.  A novel autoantibody to a 155-kd protein is associated with dermatomyositis. , 2006, Arthritis and rheumatism.

[32]  D. Lipsker,et al.  Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients. , 2006, Clinical immunology.

[33]  A. Offiah.  Acute osteomyelitis, septic arthritis and discitis: differences between neonates and older children. , 2006, European journal of radiology.

[34]  D. Gladman,et al.  Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent. , 2006, The Journal of rheumatology.

[35]  Yao-Hsu Yang,et al.  Antinucleosome antibodies correlate with the disease severity in children with systemic lupus erythematosus. , 2006, Journal of autoimmunity.

[36]  E. Zeggini,et al.  Association of HLA-DRB1*13 with susceptibility to uveitis in juvenile idiopathic arthritis in two independent data sets. , 2006, Rheumatology.

[37]  E. Märker-Hermann,et al.  Pathogenesis of ankylosing spondylitis: current concepts. , 2006, Best practice & research. Clinical rheumatology.

[38]  M. Scheinberg,et al.  Antinucleosome Antibodies in Patients with Juvenile Systemic Lupus Erythematosus , 2006, Lupus.

[39]  H. Mizumoto,et al.  Transient antiphospholipid antibodies associated with acute infections in children: a report of three cases and a review of the literature , 2006, European Journal of Pediatrics.

[40]  S. Shulman,et al.  Group A streptococcal infections. , 2006, Pediatrics in review.

[41]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[42]  E. Silverman,et al.  Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. , 2005, Blood.

[43]  K. Frauenknecht,et al.  Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infection. , 2005, Immunobiology.

[44]  J. Carcillo,et al.  Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome , 2005, Archives of Disease in Childhood.

[45]  A. Koren,et al.  Procalcitonin as a Diagnostic Aid in Osteomyelitis and Septic Arthritis , 2005, Pediatric emergency care.

[46]  R. Petty,et al.  Primary Sjögren's syndrome in children and adolescents: are proposed diagnostic criteria applicable? , 2005, The Journal of rheumatology.

[47]  Y. Shoenfeld,et al.  Protective Molecules–C-Reactive Protein (CRP), Serum Amyloid P (SAP), Pentraxin3 (PTX3), Mannose-Binding Lectin (MBL), and Apolipoprotein A1 (Apo A1), and Their Autoantibodies: Prevalence and Clinical Significance in Autoimmunity , 2005, Journal of Clinical Immunology.

[48]  Marina Ali,et al.  Proteomics in rheumatology: a new direction for old diseases. , 2005, Seminars in arthritis and rheumatism.

[49]  D. Kastner,et al.  Familial autoinflammatory diseases: genetics, pathogenesis and treatment , 2005, Current opinion in rheumatology.

[50]  S. Pierangeli,et al.  Clinical laboratory testing for the antiphospholipid syndrome. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[51]  M. Tayeh,et al.  The spectrum of familial Mediterranean fever gene mutations in Arabs: report of a large series. , 2005, Seminars in arthritis and rheumatism.

[52]  R. Hahn,et al.  Evaluation of poststreptococcal illness. , 2005, American family physician.

[53]  R. Zare,et al.  Rheumatic fever: The relationship between clinical manifestations and laboratory tests , 2005, Journal of paediatrics and child health.

[54]  A. Martini,et al.  Inherited autoinflammatory syndromes: an expanding new group of chronic inflammatory diseases. , 2005, Clinical and experimental rheumatology.

[55]  A. Martini,et al.  Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. , 2005, Arthritis and rheumatism.

[56]  Wan-Uk Kim,et al.  T cell proliferative response to type II collagen in the inflammatory process and joint damage in patients with rheumatoid arthritis. , 2005, The Journal of rheumatology.

[57]  G. Hughes,et al.  Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. , 2004, The Journal of rheumatology.

[58]  G. Burmester,et al.  Sinusoidal dilatation: a rare side effect of azathioprine , 2004, Annals of the rheumatic diseases.

[59]  Allan Wiik,et al.  Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. , 2004, Clinical chemistry.

[60]  A. Szalai.  C-Reactive Protein (CRP) and Autoimmune Disease: Facts and Conjectures , 2004, Clinical & developmental immunology.

[61]  A. Chauhan,et al.  Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. , 2004, The Journal of rheumatology.

[62]  Sampath Prahalad,et al.  Genetics of juvenile idiopathic arthritis: an update , 2004, Current opinion in rheumatology.

[63]  J. Jarvis,et al.  Clinical utility of antinuclear antibody tests in children , 2004, BMC pediatrics.

[64]  M. Gershwin,et al.  Inflamm-aging: autoimmunity, and the immune-risk phenotype. , 2004, Autoimmunity reviews.

[65]  E. Yeh.  CRP as a mediator of disease. , 2004, Circulation.

[66]  J. Sheldon.  Laboratory testing in autoimmune rheumatic diseases. , 2004, Best practice & research. Clinical rheumatology.

[67]  D. Foell,et al.  Wegener granulomatosis in childhood and adolescence , 2004, European Journal of Pediatrics.

[68]  H. Paulus,et al.  Is erythrocyte sedimentation rate the preferable measure of the acute phase response in rheumatoid arthritis? , 2004, The Journal of rheumatology.

[69]  Masahiko Kato,et al.  Serum procalcitonin concentration in patients with Kawasaki disease. , 2004, The Journal of infection.

[70]  D. Patel,et al.  Genomic-based therapy: targeting interleukin-1 for autoinflammatory diseases. , 2004, Arthritis and rheumatism.

[71]  N. Milman,et al.  Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children , 2004, Acta paediatrica.

[72]  F. Cornélis.  Genetics and clinical practice in rheumatology. , 2003, Joint, bone, spine : revue du rhumatisme.

[73]  C. Cubells,et al.  Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker , 2003 .

[74]  D. Glass,et al.  Non-HLA gene polymorphisms in juvenile rheumatoid arthritis. , 2003, Clinical and experimental rheumatology.

[75]  A. Martini,et al.  Early predictors of outcome in juvenile idiopathic arthritis. , 2003, Clinical and experimental rheumatology.

[76]  J. Kowalczyk,et al.  [Concentration of procalcitonin and C-reactive protein in serum and erythrocyte sedimentation rate in active autoimmune diseases in children]. , 2003, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[77]  C. Beyan,et al.  The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus , 2003, Scandinavian journal of rheumatology.

[78]  A. Šedivá,et al.  Primary Sjögren syndrome in the paediatric age: a multicentre survey , 2003, European Journal of Pediatrics.

[79]  P. van Paassen,et al.  Laboratory assessment in musculoskeletal disorders. , 2003, Best practice & research. Clinical rheumatology.

[80]  M. García-Carrasco,et al.  Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy , 2003, Annals of the rheumatic diseases.

[81]  J. Piette,et al.  Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? , 2003, Annals of the rheumatic diseases.

[82]  T. Barbui,et al.  Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. , 2003, Blood.

[83]  A. Šedivá,et al.  Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies. , 2003, Clinical immunology.

[84]  M. Hall,et al.  Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. , 2002, Rheumatology.

[85]  P Woo,et al.  Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. , 2002, Rheumatology.

[86]  A. García Tello,et al.  [Hematological abnormalities in patients with systemic lupus erythematosus]. , 2002, Anales de medicina interna.

[87]  D. Kastner,et al.  The TNF Receptor-Associated Periodic Syndrome (TRAPS): Emerging Concepts of an Autoinflammatory Disorder , 2002, Medicine.

[88]  A. Ravelli.  Macrophage activation syndrome. , 2002, Current opinion in rheumatology.

[89]  W. Thomson,et al.  Genetic epidemiology: Juvenile idiopathic arthritis genetics - What's new? What's next? , 2002, Arthritis research.

[90]  H. Papadaki,et al.  Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. , 2002, Blood.

[91]  M. Schaller,et al.  Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis. , 2002, Clinical and experimental rheumatology.

[92]  M. Terreri,et al.  Rheumatic fever and post-streptococcal arthritis. , 2002, Best practice & research. Clinical rheumatology.

[93]  P. Meroni,et al.  Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis , 2002, Annals of the rheumatic diseases.

[94]  L. Wagner-Weiner.  Laboratory evaluation of children with rheumatic disease. , 2002, Pediatric annals.

[95]  Joseph W Gravel,et al.  Clinical utility of common serum rheumatologic tests. , 2002, American family physician.

[96]  R. Day.  Adverse reactions to TNF-α inhibitors in rheumatoid arthritis , 2002, The Lancet.

[97]  I. Uthman,et al.  Viral infections and antiphospholipid antibodies. , 2002, Seminars in arthritis and rheumatism.

[98]  J. Drenth,et al.  Hereditary periodic fever. , 2001, The New England journal of medicine.

[99]  M. Attia,et al.  C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. , 2001, Pediatrics.

[100]  R. Stimson,et al.  The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting. , 2001, QJM : monthly journal of the Association of Physicians.

[101]  Babatyi I. Malope,et al.  The ratio of serum transferrin receptor and serum ferritin in the diagnosis of iron status , 2001, British journal of haematology.

[102]  J. Choi,et al.  The usefulness of serum transferrin receptor and ferritin for assessing anemia in rheumatoid arthritis: comparison with bone marrow iron study , 2001, Rheumatology International.

[103]  A. Tincani,et al.  Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. , 2001, Arthritis and rheumatism.

[104]  J. Volanakis,et al.  Human C-reactive protein: expression, structure, and function. , 2001, Molecular immunology.

[105]  Isabelle Touitou,et al.  The spectrum of Familial Mediterranean Fever (FMF) mutations , 2001, European Journal of Human Genetics.

[106]  M. Pepys.  Pathogenesis, diagnosis and treatment of systemic amyloidosis. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[107]  N. Brot,et al.  C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response , 2000, The Journal of experimental medicine.

[108]  M. Feldmann,et al.  Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. , 2000, Arthritis and rheumatism.

[109]  E. Hossny,et al.  Anti‐centromere antibodies as a marker of Raynaud's phenomenon in pediatric rheumatologic diseases , 2000 .

[110]  K. Kavaklı,et al.  Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection , 2000, Acta paediatrica.

[111]  M. Meisner,et al.  Procalcitonin as a marker of the systemic inflammatory response to infection , 2000, Intensive Care Medicine.

[112]  W. Egner.  The use of laboratory tests in the diagnosis of SLE , 2000, Journal of clinical pathology.

[113]  J. Rotter,et al.  Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. , 2000, Pediatrics.

[114]  J. Ioannidis,et al.  Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin , 2000, Annals of the rheumatic diseases.

[115]  M. Pepys,et al.  C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction , 1999, The Journal of experimental medicine.

[116]  J. García-González,et al.  Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus in childhood. , 1999, The Journal of rheumatology.

[117]  D. Glass,et al.  Juvenile rheumatoid arthritis as a complex genetic trait. , 1999, Arthritis and rheumatism.

[118]  A. Whitehead,et al.  Serum amyloid A, the major vertebrate acute-phase reactant. , 1999, European journal of biochemistry.

[119]  Wan Ariffin Bin Abdullah,et al.  Med Pediatr Oncol , 1999 .

[120]  Joost P.H. Drenth,et al.  Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome , 1999, Nature Genetics.

[121]  M. Greaves,et al.  Antiphospholipid antibodies and thrombosis , 1999, The Lancet.

[122]  M. Greaves.  Antiphospholipid antibodies and thrombosis , 1999, The Lancet.

[123]  Ian Todd,et al.  Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes , 1999, Cell.

[124]  J. Morrison,et al.  Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. , 1999, Human molecular genetics.

[125]  T. Jaskowski,et al.  Comparison of Three Different Methods for Measuring Classical Pathway Complement Activity , 1999, Clinical Diagnostic Laboratory Immunology.

[126]  M. Petri,et al.  Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[127]  A. Šedivá,et al.  Antineutrophil cytoplasmic antibodies in children , 1998, European Journal of Pediatrics.

[128]  M. Belfer,et al.  Sarcoidosis: a primary care review. , 1998, American family physician.

[129]  J. Sipe,et al.  Analytical Evaluation of Particle-Enhanced Immunonephelometric Assays for C-Reactive Protein, Serum Amyloid a and Mannose-Binding Protein in Human Serum , 1998, Annals of clinical biochemistry.

[130]  A. Dyer,et al.  Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. , 1998, The Journal of rheumatology.

[131]  M. Brigden.  The erythrocyte sedimentation rate: Still a helpful test when used judiciously , 1998 .

[132]  R. Falk,et al.  Diagnostic predictive value of ANCA serology. , 1998, Kidney international.

[133]  A. Tzioufas,et al.  Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus: correlation with anemia. , 1997, Arthritis and rheumatism.

[134]  M. Sailer,et al.  Usefulness of antinuclear antibody testing to screen for rheumatic diseases , 1997, Archives of disease in childhood.

[135]  F. Wolfe.  Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. , 1997, The Journal of rheumatology.

[136]  D. Felson,et al.  Preliminary definition of improvement in juvenile arthritis. , 1997, Arthritis and rheumatism.

[137]  M. Haubitz,et al.  Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection , 1997 .

[138]  F. Guillemin,et al.  Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysis , 1997, Lupus.

[139]  D. Schultz.  Antiphospholipid antibodies: basic immunology and assays. , 1997, Seminars in arthritis and rheumatism.

[140]  G. Iverson,et al.  Are Antibodies to Ribosomal P Proteins a Clinically Useful Predictor of Neuropsychiatric Manifestations in Patients with Systemic Lupus Erythematosus? , 1996, Lupus.

[141]  M. Dougados,et al.  Synovial fluid cell analysis. , 1996, Bailliere's clinical rheumatology.

[142]  M. Cazzola,et al.  Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. , 1996, Blood.

[143]  A. Singh,et al.  Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. , 1996, Journal of the American Society of Nephrology : JASN.

[144]  K. Elkon,et al.  Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. , 1996, Arthritis and rheumatism.

[145]  N. Casadevall,et al.  Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. , 1996, The New England journal of medicine.

[146]  C. Moertel,et al.  Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. , 1996, The Journal of pediatrics.

[147]  W. D. Ratnoff,et al.  Inherited deficiencies of complement in rheumatic diseases. , 1996, Rheumatic diseases clinics of North America.

[148]  D. Schultz,et al.  Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations. , 1995, Seminars in arthritis and rheumatism.

[149]  J. Baum,et al.  The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. , 1995, Pediatrics.

[150]  C. An,et al.  Enigmas in sarcoidosis. , 1995 .

[151]  E. Tan,et al.  Autoantibodies in the diagnosis of systemicrheumatic diseases , 1995 .

[152]  S. Jacobsen,et al.  Tumor necrosis factor (TNF)-alpha directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors. , 1995, Blood.

[153]  R. Deremee.  Concise Review for Primary-Care PhysiciansSarcoidosis , 1995 .

[154]  G. Marhaug,et al.  Serum amyloid A: an acute phase apolipoprotein and precursor of AA amyloid. , 1994, Bailliere's clinical rheumatology.

[155]  Bernstein Rm.  Autoantibodies in myositis. , 1993, Bailliere's clinical neurology.

[156]  S. Krantz,et al.  Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. , 1993, The Journal of clinical investigation.

[157]  S. Krantz,et al.  Progress in understanding the pathogenesis of the anemia of chronic disease. , 1992, Blood.

[158]  M. Mihatsch,et al.  Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. , 1992, The New England journal of medicine.

[159]  D. Kastner,et al.  Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. , 1992, The New England journal of medicine.

[160]  K. Hsieh,et al.  A long-term immunological study of childhood onset systemic lupus erythematosus. , 1992, Annals of the rheumatic diseases.

[161]  R. Means,et al.  Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin. , 1991, Blood.

[162]  J. Nossent,et al.  Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. , 1991, The Quarterly journal of medicine.

[163]  P. Venables,et al.  Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block. , 1991, Journal of autoimmunity.

[164]  P. Limburg,et al.  Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. , 1990, Arthritis and rheumatism.

[165]  C. Baltus,et al.  Anaemia of chronic disease: diagnostic significance of erythrocyte and serological parameters in iron deficient rheumatoid arthritis patients. , 1990, British journal of rheumatology.

[166]  A. Allison,et al.  Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias. , 1987 .

[167]  O. Vaarala,et al.  Anticardiolipin response in acute infections. , 1986, Clinical immunology and immunopathology.

[168]  R. Cebul,et al.  Utility of rheumatoid factor in the diagnosis of juvenile rheumatoid arthritis. , 1986, Pediatrics.

[169]  Shearn Ma,et al.  Effect of age and sex on the erythrocyte sedimentation rate. , 1986 .

[170]  M. Liang,et al.  The erythrocyte sedimentation rate. Guidelines for rational use. , 1986, Annals of internal medicine.

[171]  M. Siimes,et al.  Ferritinemia as an Indicator of Systemic Disease Activity in Children with Systemic Juvenile Rheumatoid Arthritis , 1986, Acta paediatrica Scandinavica.

[172]  C. Mackworth-Young,et al.  ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS , 1983, The Lancet.

[173]  J. E. Moran,et al.  Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? , 1982, British medical journal.

[174]  B. Ansell,et al.  C-reactive protein in juvenile chronic arthritis: an indicator of disease activity and possibly amyloidosis. , 1982, Annals of the rheumatic diseases.

[175]  M. Pepys,et al.  C-reactive protein in SLE. , 1982, Clinics in rheumatic diseases.

[176]  B. Amor,et al.  Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA). , 1978, Annals of the rheumatic diseases.

[177]  P. Lambert,et al.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. , 1975, The Journal of clinical investigation.

[178]  G. Stollerman,et al.  Relationship of immune response to group A streptococci to the course of acute, chronic and recurrent rheumatic fever. , 1956, The American journal of medicine.

[179]  Thomas Francis,et al.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS , 1930, The Journal of experimental medicine.

[180]  R. Laxer,et al.  PHARMACOLOGY AND DRUG THERAPY , 2011 .

[181]  Carl Gustav Jung.  The Red Book , 2009 .

[182]  Zhanguo Li,et al.  Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus. , 2007, Clinical immunology.

[183]  D. D'cruz,et al.  Managing antiphospholipid antibodies and antiphospholipid syndrome in children. , 2006, Haematologica.

[184]  J. Kowalczyk.  Professor Edmund Biernacki (1866 - 1911) and the discovery of the erythrocyte sedimentation rate. , 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[185]  D. Kastner,et al.  The systemic autoinflammatory diseases: inborn errors of the innate immune system. , 2006, Current topics in microbiology and immunology.

[186]  Y. Kanakura,et al.  The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. , 2006, Haematologica.

[187]  M. Rewers,et al.  Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[188]  S. Giannouli,et al.  Anemia in Systemic lupus erythematosus: from pathophysiology to clinical assessment , 2005 .

[189]  C. Mold,et al.  C-reactive protein , 2004, Immunologic research.

[190]  L. Leiva,et al.  Antinuclear Antibody (ANA) and ANA Profile Tests in Children with Autoimmune Disorders: A Retrospective Study , 2000, Clinical Rheumatology.

[191]  B. Pal,et al.  Is routine synovial fluid analysis necessary? Lessons and recommendations from an audit , 1999, Rheumatology International.

[192]  R. Kalluri,et al.  Structural features of nephritogenic lupus autoantibodies. , 1997, Methods.

[193]  L. Pachman.  Juvenile dermatomyositis (JDMS): new clues to diagnosis and pathogenesis. , 1994, Clinical and experimental rheumatology.

[194]  Elizabeth C. Theil.  Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. , 1987, Annual review of biochemistry.

[195]  M. Andreeff,et al.  Serum LDH values in childhood acute leukemias and non-Hodgkin's lymphoma. , 1984, Medical and pediatric oncology.

[196]  R. Petty,et al.  Textbook of pediatric rheumatology , 1982 .

[197]  C. Conley.  A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus , 1952 .